BFRI Valuation

Biofrontera Inc

Add to Watchlist

Advanced Chart

1.060

-0.045(-4.072%)1D

Overview
Forecast
Valuation
Earnings

BFRI Relative Valuation

BFRI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BFRI is overvalued; if below, it's undervalued.

Historical Valuation

Biofrontera Inc (BFRI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.20 is considered Undervalued compared with the five-year average of -13.79. The fair price of Biofrontera Inc (BFRI) is between 2.70 to 2.94 according to relative valuation methord. Compared to the current price of 1.10 USD , Biofrontera Inc is Undervalued By 59.07%.

Relative Value

Fair Zone

2.70-2.94

Current Price：1.10

59.07%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

20.91

P/B

Median3y

2.21

Median5y

2.27

-108.00

FCF Yield

Median3y

-265.22

Median5y

-220.81

Competitors Valuation Multiple

The average P/S ratio for BFRI's competitors is 1.82, providing a benchmark for relative valuation. Biofrontera Inc Corp (BFRI) exhibits a P/S ratio of 0.24, which is -86.88% above the industry average. Given its robust revenue growth of 8.54%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap